ClinicalTrials.gov
public full text
Public Domain
Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
Acute respiratory distress syndrome (ARDS) in neonates has been defined, the role of surfactant is not clear. This study aimed to determine whether ARDS neonate would benefit from surfactant when oxygenation deteriorated on mechanical ventilation and to identify any potential risk factors related to mortality.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term Respiratory Complications in Infants With Perinatal COVID-19#1072175
- I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures#1088014
- Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study#886646
- Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials#1089849
- Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)#901626
Record · ID 1163200
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive